2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

About the Guideline

• Developed by the American College of Cardiology/American Heart Association task force on practice guidelines in collaboration with the National Heart, Lung, and Blood Institute (NHLBI) in an effort to provide guidelines for the assessment of cardiovascular (CV) risk to promote optimal CV health and prevent CV disease.
• The objective of this publication was to develop an approach to quantify risk assessment in order to guide care and to address key clinical questions surrounding the assessment of CV risk targeting asymptomatic patients in the general population (e.g., those with no history of atherosclerotic cardiovascular disease [ASCVD]).
• The three major areas of focus were developing a risk assessment tool and addressing 2 key clinical questions (CQ) for which 7 recommendations were made.
• The intent of the guideline is to target adults with no signs or symptoms of atherosclerotic cardiovascular disease (ASCVD) who would benefit from primary prevention.

Key Clinical Considerations

The ACC/AHA ASCVD Risk Calculator (Goff et al., 2014)

Recommendation 1

Recommendation 2

Recommendation 3

Recommendation 4

Recommendation 5

Recommendation 6

Recommendation 7

Reference